Rubens Brito

Learn More
INTRODUCTION  The bone-anchored hearing aid (BAHA) is a bone conduction hearing device that transmits sound directly into the inner ear. It is mainly used in patients with conductive hearing loss associated with aural atresia, but it is also used in those with mixed and sensorineural hearing loss. GOALS  To review the main indications for BAHA, to analyze(More)
Introduction Currently the cochlear implant allows access to sounds in individuals with profound hearing loss. The objective methods used to verify the integrity of the cochlear device and the electrophysiologic response of users have noted these improvements. Objective To establish whether the evoked compound action potential of the auditory nerve can(More)
CONCLUSION The extended retrolabyrinthine approach (RLA) is a safe and reliable approach for auditory brainstem placement in children. The surgical landmarks to reach cochlear nucleus are adequately exposed by this approach. OBJECTIVE To describe a new approach option for auditory brainstem implants (ABIs) in children, highlighting the anatomical(More)
OBJECTIVE To identify the technological contributions of the newer version of speech processor to the first generation of multichannel cochlear implant and the satisfaction of users of the new technology. Among the new features available, we focused on the effect of the frequency allocation table, the T-SPL and C-SPL, and the preprocessing gain adjustments(More)
INTRODUCTION  The most relevant clinical symptom in Waardenburg syndrome is profound bilateral sensorioneural hearing loss. AIM  To characterize and describe hearing outcomes after cochlear implantation in patients with Waardenburg syndrome to improve preoperative expectations. METHOD  This was an observational and retrospective study of a series of(More)
UNLABELLED New technology in the Freedom® speech processor for cochlear implants was developed to improve how incoming acoustic sound is processed; this applies not only for new users, but also for previous generations of cochlear implants. AIM To identify the contribution of this technology-- the Nucleus 22®--on speech perception tests in silence and in(More)
  • 1